These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23492913)

  • 1. Mild haemophilia B from a novel missense mutation Ser350Ala of the F9 gene.
    Park CH; Seo JY; Kim SH; Koo HH; Kim HJ
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):544-6. PubMed ID: 23492913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diagnostic challenge: mild hemophilia B with normal activated partial thromboplastin time.
    Park CH; Seo JY; Kim HJ; Jang JH; Kim SH
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):368-71. PubMed ID: 20305539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B.
    Wang X; Tang N; Shen N; Zhu Y; Lu Y; Gao L
    Hematology; 2020 Dec; 25(1):484-488. PubMed ID: 33295842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel missense mutation in F9 gene causes hemophilia B in a family with clinical variability.
    Yi S; Yang Q; Zuo Y; Li M; Luo J; Qin Z; Zhang Q; Li M; Huang L; Lu Y; Feng S; Fan X
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):121-126. PubMed ID: 31904612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of factor IX mutations in Iranian haemophilia B patients by SSCP and sequencing.
    Karimipoor M; Zeinali S; Nafissi N; Tuddenham EG; Lak M; Safaee R
    Thromb Res; 2007; 120(1):135-9. PubMed ID: 17014892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal low-level somatic mosaicism of Cys155Tyr of F9 in severe hemophilia B.
    Kim HJ; Lee KO; Yoo KY; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):866-8. PubMed ID: 25402191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B--Factor IXDelhi.
    Mahajan A; Sharma A; Chavali S; Kabra M; Chowdhury MR; Srinivasan N; Bharadwaj D
    Haemophilia; 2004 Sep; 10(5):550-2. PubMed ID: 15357782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F8 and F9 mutations fail to co-segregate in a family with co-incident haemophilia A and B.
    Siddiq S; Morse C; Goodeve A; Panayi M; Tait RC; Mumford A
    Haemophilia; 2011 Jan; 17(1):e230-4. PubMed ID: 20860608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilia B caused by a missense mutation in the prepeptide sequence of factor IX.
    Green PM; Mitchell VE; McGraw A; Goldman E; Giannelli F
    Hum Mutat; 1993; 2(2):103-7. PubMed ID: 8318985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect.
    Jenkins PV; Egan H; Keenan C; O'Shea E; Smith OP; Nolan B; White B; O'Donnell J
    Haemophilia; 2008 Jul; 14(4):717-22. PubMed ID: 18479429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilia B: from molecular diagnosis to gene therapy.
    Castaldo G; Nardiello P; Bellitti F; Santamaria R; Rocino A; Coppola A; di Minno G; Salvatore F
    Clin Chem Lab Med; 2003 Apr; 41(4):445-51. PubMed ID: 12747585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into molecular changes of the FIX protein in a series of Italian patients with haemophilia B.
    Bicocchi MP; Pasino M; Rosano C; Molinari AC; Della Valle E; Lanza T; Bottini F; Acquila M
    Haemophilia; 2006 May; 12(3):263-70. PubMed ID: 16643212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene diagnosis of 3 haemophilia B families].
    Zhang Y; Yang LH; Lu YL; Ding QL; Wang XF; Liu XE; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):179-82. PubMed ID: 18788618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
    Sharathkumar A; Hardesty B; Greist A; Salter J; Kerlin B; Heiman M; Sulkin M; Shapiro A
    Haemophilia; 2009 Jan; 15(1):91-100. PubMed ID: 18721150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor IX mutations in haemophilia B patients in Malaysia: a preliminary study.
    Balraj P; Ahmad M; Khoo AS; Ayob Y
    Malays J Pathol; 2012 Jun; 34(1):67-9. PubMed ID: 22870602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
    Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
    Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics and spectrum of F9 mutations in Chinese sporadic haemophilia B pedigrees.
    Lu Y; Wu X; Dai J; Ding Q; Wu W; Wang X
    Haemophilia; 2019 Mar; 25(2):316-323. PubMed ID: 30648777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G244E in the canine factor IX gene leads to severe haemophilia B in Rhodesian Ridgebacks.
    Mischke R; Kühnlein P; Kehl A; Langbein-Detsch I; Steudle F; Schmid A; Dandekar T; Czwalinna A; Müller E
    Vet J; 2011 Jan; 187(1):113-8. PubMed ID: 20303304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.